Abstract
Proteins are a diverse group of biomolecules that have many different biological activities and structures. Both in the industrial and research laboratory, proteins are used for very diverse purposes and are produced at different scales. Main fields of application of proteins are human and animal prophylactics, therapeutics, and diagnostics, as well as the food processing industry. Besides, proteins are employed as additives to generate a diverse range of products. Pectinases are employed in the food industry since 1930, in fruit juice manufacturing; other enzymes like papain, bromelain, pepsin, rennin, lipases, cellulases, and amylases have several industrial applications. Due to their relevance in medicine, proteins used as biopharmaceuticals are the best characterized. This chapter addresses the production of recombinant proteins as aligned with the concept of industrial sustainability and Escherichia coli as a model for heterologous protein production. It describes and updates the main production strategies and the current available tools for the protein expression system. The main disadvantages, as well as the improvements done to this model, are detailed. A final summary that includes industrial uses and fields of applications of recombinant proteins points out the relevance of this prokaryotic system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arie JP, Miot M, Sassoon N, Betton JM (2006) Formation of active inclusion bodies in the periplasm of Escherichia coli. Mol Microbiol 62(2):427–437
Austin S, Nordstrom K (1990) Partition-mediated incompatibility of bacterial plasmids. Cell 60(3):351–354
Baeshen MN, Al-Hejin AM, Bora RS, Ahmed MM, Ramadan HA, Saini KS, Baeshen NA, Redwan EM (2015) Production of biopharmaceuticals in E. coli: current scenario and future perspectives. J Microbiol Biotechnol 25(7):953–962
Baneyx F, Mujacic M (2004) Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 22(11):1399–1408
Bayer ME, Bayer MH, Lunn CA, Pigiet V (1987) Association of thioredoxin with the inner membrane and adhesion sites in Escherichia coli. J Bacteriol 169(6):2659–2666
Bentley R, Meganathan R (1982) Biosynthesis of vitamin K (menaquinone) in bacteria. Microbiol Rev 46(3):241–280
Burgess RR (2009) Refolding solubilized inclusion body proteins. Methods Enzymol 463:259–282
Burgess RR, Deutscher MP (eds) (2009) Methods in enzymology. Guide to protein purification, vol 463. Methods Enzymol, 2009/11/07 edn. Elsevier
Carson M, Johnson DH, McDonald H, Brouillette C, Delucas LJ (2007) His-tag impact on structure. Acta Crystallogr D Biol Crystallogr 63(Pt 3):295–301
Castillo V, Grana-Montes R, Sabate R, Ventura S (2011) Prediction of the aggregation propensity of proteins from the primary sequence: aggregation properties of proteomes. Biotechnol J 6(6):674–685
Choi JH, Lee SY (2004) Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 64(5):625–635
Chow MK, Amin AA, Fulton KF, Fernando T, Kamau L, Batty C, Louca M, Ho S, Whisstock JC, Bottomley SP, Buckle AM (2006) The REFOLD database: a tool for the optimization of protein expression and refolding. Nucleic Acids Res 34(Database issue):D207–D212
Correa A, Oppezzo P (2011) Tuning different expression parameters to achieve soluble recombinant proteins in E. coli: advantages of high-throughput screening. Biotechnol J 6(6):715–730
Correa A, Oppezzo P (2015) Overcoming the solubility problem in E. coli: available approaches for recombinant protein production. Methods Mol Biol 1258:27–44
Cortazzo P, Cervenansky C, Marin M, Reiss C, Ehrlich R, Deana A (2002) Silent mutations affect in vivo protein folding in Escherichia coli. Biochem Biophys Res Commun 293(1):537–541
Cuccui J, Wren B (2015) Hijacking bacterial glycosylation for the production of glycoconjugates, from vaccines to humanised glycoproteins. J Pharm Pharmacol 67(3):338–350
de Groot NS, Castillo V, Grana-Montes R, Ventura S (2012) AGGRESCAN: method, application, and perspectives for drug design. Methods Mol Biol 819:199–220
Deana A, Ehrlich R, Reiss C (1998) Silent mutations in the Escherichia coli ompA leader peptide region strongly affect transcription and translation in vivo. Nucleic Acids Res 26(20):4778–4782
Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27(3):297–306
Denoncin K, Collet JF (2013) Disulfide bond formation in the bacterial periplasm: major achievements and challenges ahead. Antioxid Redox Signal 19(1):63–71
Duong-Ly KC, Gabelli SB (2015) Affinity purification of a recombinant protein expressed as a fusion with the Maltose-Binding Protein (MBP) tag. Methods Enzymol 559:17–26
Emtage JS, Angal S, Doel MT, Harris TJ, Jenkins B, Lilley G, Lowe PA (1983) Synthesis of calf prochymosin (prorennin) in Escherichia coli. Proc Natl Acad Sci U S A 80(12):3671–3675
Fergus C, Barnes D, Alqasem MA, Kelly VP (2015) The queuine micronutrient: charting a course from microbe to man. Nutrients 7(4):2897–2929
Garcia-Fruitos E, Sabate R, de Groot NS, Villaverde A, Ventura S (2011) Biological role of bacterial inclusion bodies: a model for amyloid aggregation. FEBS J 278(14):2419–2427
Gavrilescu M, Chisti Y (2005) Biotechnology-a sustainable alternative for chemical industry. Biotechnol Adv 23(7–8):471–499
Georgiou G, Segatori L (2005) Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr Opin Biotechnol 16(5):538–545
Hammond B (2007) The food safety assessment of bovine somatotropin (bST). In: Hammond B (ed) Food safety of proteins in agricultural biotechnology. CRC Press, New York, pp 167–208. doi:10.1201/9781420005738.ch7
Hardin DS (2008) Treatment of short stature and growth hormone deficiency in children with somatotropin (rDNA origin). Biologics 2(4):655–661
Hayashi K, Kojima C (2008) pCold-GST vector: a novel cold-shock vector containing GST tag for soluble protein production. Protein Expr Purif 62(1):120–127
Hess AK, Saffert P, Liebeton K, Ignatova Z (2015) Optimization of translation profiles enhances protein expression and solubility. PLoS One 10(5):e0127039
Jackwood M, Hickle L, Kapil S, Silva R (2008) Vaccine development using recombinant DNA technology. Council Agric Sci Technol 38:1–11
Kaplan W, Husler P, Klump H, Erhardt J, Sluis-Cremer N, Dirr H (1997) Conformational stability of pGEX-expressed Schistosoma japonicum glutathione S-transferase: a detoxification enzyme and fusion-protein affinity tag. Protein Sci 6(2):399–406
Kapust RB, Waugh DS (1999) Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci 8(8):1668–1674
Keefer LM, Piron MA, De Meyts P (1981) Human insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptors. Proc Natl Acad Sci U S A 78(3):1391–1395
Kroll J, Klinter S, Schneider C, Voss I, Steinbuchel A (2010) Plasmid addiction systems: perspectives and applications in biotechnology. Microb Biotechnol 3(6):634–657
Kurland CG (1991) Codon bias and gene expression. FEBS Lett 285(2):165–169
Kuznetsova IM, Turoverov KK, Uversky VN (2014) What macromolecular crowding can do to a protein. Int J Mol Sci 15(12):23090–23140
LaVallie ER, DiBlasio EA, Kovacic S, Grant KL, Schendel PF, McCoy JM (1993) A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology 11(2):187–193
Leader B, Baca QJ, Golan DE (2008) Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 7(1):21–39
Li Y (2011) Self-cleaving fusion tags for recombinant protein production. Biotechnol Lett 33(5):869–881
Lorsch JR (ed) (2015) Laboratory methods in enzymology: protein part D, vol 559. Meth Enzymol, 2015/06/23 edn, Academic Press (Elsevier)
Lu Z, DiBlasio-Smith EA, Grant KL, Warne NW, LaVallie ER, Collins-Racie LA, Follettie MT, Williamson MJ, McCoy JM (1996) Histidine patch thioredoxins. Mutant forms of thioredoxin with metal chelating affinity that provide for convenient purifications of thioredoxin fusion proteins. J Biol Chem 271(9):5059–5065
Mamat U, Wilke K, Bramhill D, Schromm AB, Lindner B, Kohl TA, Corchero JL, Villaverde A, Schaffer L, Head SR, Souvignier C, Meredith TC, Woodard RW (2015) Detoxifying Escherichia coli for endotoxin-free production of recombinant proteins. Microb Cell Fact 14:57
Miot M, Betton JM (2004) Protein quality control in the bacterial periplasm. Microb Cell Fact 3(1):4
Neidhardt FC, Curtiss R, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff W, Riley M, Schaechter M, Umbarger HE (1996) Escherichia coli and Salmonella: cellular and molecular biology, vol 1, 2nd edn. Society for Microbiology (ASM) Press, Washington, DC
Olempska-Beer ZS, Merker RI, Ditto MD, DiNovi MJ (2006) Food-processing enzymes from recombinant microorganisms–a review. Regul Toxicol Pharmacol 45(2):144–158
Papaneophytou CP, Kontopidis G (2014) Statistical approaches to maximize recombinant protein expression in Escherichia coli: a general review. Protein Expr Purif 94:22–32
Peubez I, Chaudet N, Mignon C, Hild G, Husson S, Courtois V, De Luca K, Speck D, Sodoyer R (2010) Antibiotic-free selection in E. coli: new considerations for optimal design and improved production. Microb Cell Fact 9:65
Puigbo P, Guzman E, Romeu A, Garcia-Vallve S (2007) OPTIMIZER: a web server for optimizing the codon usage of DNA sequences. Nucleic Acids Res 35 (Web Server issue):W126–131
Rader R, Langer E (2015) Biopharmaceutical manufacturing: historical and future trends in titers, yields, and efficiency in commercial-scale bioprocessing. Bioprocess J 13(4):47–54
Ramon A, Senorale-Pose M, Marin M (2014) Inclusion bodies: not that bad. Front Microbiol 5:56
Rosano GL, Ceccarelli EA (2009) Rare codon content affects the solubility of recombinant proteins in a codon bias-adjusted Escherichia coli strain. Microb Cell Fact 8:41
Rosano GL, Ceccarelli EA (2014) Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 5:172
Rudge P, Jaunmuktane Z, Adlard P, Bjurstrom N, Caine D, Lowe J, Norsworthy P, Hummerich H, Druyeh R, Wadsworth JD, Brandner S, Hyare H, Mead S, Collinge J (2015) Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain 138(Pt 11):3386–3399
Ryan MP, Walsh G (2012) Veterinary-based biopharmaceuticals. Trends Biotechnol 30(12):615–620
Saez NJ, Vincentelli R (2014) High-throughput expression screening and purification of recombinant proteins in E. coli. Methods Mol Biol 1091:33–53
Salinas G, Pellizza L, Margenat M, Flo M, Fernandez C (2011) Tuned Escherichia coli as a host for the expression of disulfide-rich proteins. Biotechnol J 6(6):686–699
Sanchez-Garcia L, Martin L, Mangues R, Ferrer-Miralles N, Vazquez E, Villaverde A (2016) Recombinant pharmaceuticals from microbial cells: a 2015 update. Microb Cell Fact 15(1):33
Schafer F, Seip N, Maertens B, Block H, Kubicek J (2015) Purification of GST-tagged proteins. Meth Enzymol 559:127–139
Shur O, Dooley K, Blenner M, Baltimore M, Banta S (2013) A designed, phase changing RTX-based peptide for efficient bioseparations. Biotechniques 54(4):197–198, 200, 202, 204, 206
Smith DB, Johnson KS (1988) Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67(1):31–40
Spriestersbach A, Kubicek J, Schafer F, Block H, Maertens B (2015) Purification of His-tagged proteins. Meth Enzymol 559:1–15
Tyedmers J, Mogk A, Bukau B (2010) Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 11(11):777–788
Valdez-Cruz NA, Caspeta L, Perez NO, Ramirez OT, Trujillo-Roldan MA (2010) Production of recombinant proteins in E. coli by the heat inducible expression system based on the phage lambda pL and/or pR promoters. Microb Cell Fact 9:18
Vasina JA, Peterson MS, Baneyx F (1998) Scale-up and optimization of the low-temperature inducible cspA promoter system. Biotechnol Prog 14(5):714–721
Wacker M, Linton D, Hitchen PG, Nita-Lazar M, Haslam SM, North SJ, Panico M, Morris HR, Dell A, Wren BW, Aebi M (2002) N-linked glycosylation in Campylobacter jejuni and its functional transfer into E. coli. Science 298(5599):1790–1793
Walsh G (2014) Biopharmaceutical benchmarks 2014. Nat Biotechnol 32(10):992–1000
Yoon SH, Kim SK, Kim JF (2010) Secretory production of recombinant proteins in Escherichia coli. Recent Pat Biotechnol 4(1):23–29
Zalucki YM, Jones CE, Ng PS, Schulz BL, Jennings MP (2010) Signal sequence non-optimal codons are required for the correct folding of mature maltose binding protein. Biochim Biophys Acta 1798(6):1244–1249
Zalucki YM, Beacham IR, Jennings MP (2011) Coupling between codon usage, translation and protein export in Escherichia coli. Biotechnol J 6(6):660–667
Zambrano R, Jamroz M, Szczasiuk A, Pujols J, Kmiecik S, Ventura S (2015) AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures. Nucleic Acids Res 43(W1):W306–W313
Acknowledgments
This work was partially supported by Agencia Nacional de Investigación e Innovación (ANII, Uruguay) through Fondo María Viñas (FMV_3_2013_1_100859). Victoria Veroli was the recipient of fellowships from ANII (Uruguay).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Singapore
About this chapter
Cite this chapter
Tucci, P., Veroli, V., Señorale, M., Marín, M. (2016). Escherichia coli: The Leading Model for the Production of Recombinant Proteins. In: Castro-Sowinski, S. (eds) Microbial Models: From Environmental to Industrial Sustainability. Microorganisms for Sustainability, vol 1. Springer, Singapore. https://doi.org/10.1007/978-981-10-2555-6_6
Download citation
DOI: https://doi.org/10.1007/978-981-10-2555-6_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-2554-9
Online ISBN: 978-981-10-2555-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)